RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ENZN
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Weaker technical forecast for Enzon Pharmaceuticals as stock downgraded to Hold/Accumulate.
(Updated on Mar 28, 2024)

Buy or Hold candidate since Mar 27, 2024 PDF

No changes to the price of Enzon Pharmaceuticals stock on the last trading day (Thursday, 28th Mar 2024). During the last trading day the stock fluctuated 0% from a day low at $0.0945 to a day high of $0.0945. The price has risen in 5 of the last 10 days and is up by 14.13% over the past 2 weeks.

The stockhas broken the very wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction, there will be support on the roof of the current trend broken, which is $0.0941, a level that may pose a second chance to hit a runner. According to fan-theory $0.131 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ENZN Signals & Forecast

The Enzon Pharmaceuticals stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.0808 and $0.0801. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, March 27, 2024, and so far it has fallen 0%. Further fall is indicated until a new bottom pivot has been found. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Buy
Special Signal Notification

Double Bottom Formation

Double Bottom Formation A buy signal from a double bottom formation was found on Monday, March 04, 2024 with a target of $0.0903. Despite whether the objective of the signal formation has been reached the stock may continue to perform well.

Support, Risk & Stop-loss for Enzon Pharmaceuticals stock

Enzon Pharmaceuticals finds support from accumulated volume at $0.0936 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 14.74%

Our recommended stop-loss: $0.0910 (-3.74%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (ENZN) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Enzon Pharmaceuticals to open at $0.0945, and during the day (based on 14 day Average True Range), to move between $0.0829 and $0.106, which gives a possible trading interval of +/-$0.0116 (+/-12.25%) up or down from last closing price. If Enzon Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 24.50% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.0936 (1.01%) than the resistance at $0.0963 (1.85%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Enzon Pharmaceuticals stock A Buy?

Enzon Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

Current score: -0.135 Hold/Accumulate Downgraded

Predicted Opening Price for Enzon Pharmaceuticals of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$0.0945 ( 0.00000000%) $0.0945

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ENZN

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.0945 0.00000000 %
R2 0.0945 0.00000000 %
R1 0.0945 0.00000000 %
Current price: 0.0945
Support S1 0.0945 0.00000000 %
S2 0.0945 0.00000000 %
S3 0.0945 0.00000000 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.115 21.69 %
R2 0.101 7.20 %
R1 0.0963 1.85 %
Current price 0.0945
Support S1 0.0936 -1.01%
S2 0.0828 -12.38%
S3 0.0800 -15.34%

ENZN Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Sep 30, 2019 Sep 30, 2019 Oct 15, 2019 $0.120 52.17%
2 Feb 20, 2019 Feb 20, 2019 Feb 20, 2019 $0.0600 26.09%
3 Sep 29, 2017 Sep 29, 2017 Sep 29, 2017 $0.150 62.51%
4 Dec 13, 2016 Dec 13, 2016 Dec 13, 2016 $0.150 44.72%
5 Dec 30, 2015 Dec 30, 2015 Dec 30, 2015 $0.250 36.23%

FAQ

What is the symbol for Enzon Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Enzon Pharmaceuticals is ENZN and it is traded on the OTCMKTS (OTC Markets Group).

Should I buy or sell Enzon Pharmaceuticals Stock?
Enzon Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

How to buy Enzon Pharmaceuticals Stock?
Enzon Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Enzon Pharmaceuticals Stock.

What's the current price of Enzon Pharmaceuticals Stock?
As of the end of day on the 2024-03-28, the price of an Enzon Pharmaceuticals (ENZN) share was $0.0945.

What is the 52-week high and low for Enzon Pharmaceuticals Stock?
The 52-week high for Enzon Pharmaceuticals Stock is $0.260 and the 52-week low is $0.0600.

What is the market capitalization of Enzon Pharmaceuticals Stock?
As of the 2024-03-28, the market capitalization of Enzon Pharmaceuticals is 7.013M.

When is the next earnings date for Enzon Pharmaceuticals?
The upcoming earnings date for Enzon Pharmaceuticals is May 06, 2024.
Click to get the best stock tips daily for free!

About Enzon Pharmaceuticals

Enzon Pharmaceuticals Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey.... ENZN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT